|
|
|
|
| LEADER |
00000nam a2200000Ia 4500 |
| 100 |
|
|
|a Silverman,Richard B
|
| 250 |
|
|
|a 2nd edn
|
| 020 |
|
|
|
| 650 |
|
|
|
| 245 |
|
|
|a Organic chemistry of drug design and drug action
|
| 260 |
|
|
|a Amsterdam
|b Elsevier
|c 2012
|
| 082 |
|
|
|a 615.3
|b SIL/
|
| 300 |
|
|
|a xiii,617
|
| 952 |
|
|
|0 0
|1 0
|4 0
|6 615_300000000000000_SIL
|7 0
|9 3209
|a 00000036
|b 00000036
|d 2013-12-27
|g 1795.00
|l 4
|o 615.3/SIL
|p 5402
|r 2018-12-22 00:00:00
|s 2018-11-27
|w 2017-05-14
|y BK
|
| 952 |
|
|
|0 0
|1 0
|4 0
|6 615_300000000000000_SIL
|7 0
|9 3210
|a 00000036
|b 00000036
|d 2013-12-27
|g 1795.00
|l 7
|o 615.3/SIL
|p 5403
|r 2018-12-22 00:00:00
|s 2018-11-27
|w 2017-05-14
|y BK
|
| 952 |
|
|
|0 0
|1 0
|4 0
|6 615_300000000000000_SIL
|7 0
|9 3211
|a 00000036
|b 00000036
|d 2013-12-27
|g 1795.00
|l 3
|o 615.3/SIL
|p 5404
|r 2018-12-24 00:00:00
|s 2018-11-27
|w 2017-05-14
|y BK
|
| 952 |
|
|
|0 0
|1 0
|4 0
|6 615_300000000000000_SIL
|7 0
|9 3212
|a 00000036
|b 00000036
|d 2013-12-27
|g 1795.00
|l 4
|o 615.3/SIL
|p 5405
|r 2024-07-24 11:32:42
|s 2024-07-24
|w 2017-05-14
|y BK
|
| 952 |
|
|
|0 0
|1 0
|4 0
|6 615_300000000000000_SIL
|7 0
|9 3213
|a 00000036
|b 00000036
|d 2013-12-27
|g 1795.00
|l 5
|o 615.3/SIL
|p 5406
|r 2018-11-27 00:00:00
|s 2018-11-27
|w 2017-05-14
|y BK
|
| 999 |
|
|
|c 973
|d 973
|